{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:08:17Z","timestamp":1779916097772,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020950","name":"Department of Pathology, Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.anndiagpath.2024.152286","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T04:41:19Z","timestamp":1709181679000},"page":"152286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications"],"prefix":"10.1016","volume":"70","author":[{"given":"Ashley K.","family":"Volaric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheren F.","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152286_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0010","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0015","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0020","first-page":"9","article-title":"The global landscape of EBV-associated tumors","author":"Shannon-Lowe","year":"2019","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.anndiagpath.2024.152286_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr virus and cancer","volume":"2018","author":"Farrell","year":"2019","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/his.14379","article-title":"The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment","volume":"79","author":"Ababneh","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0040","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1128\/JVI.02241-06","article-title":"Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells","volume":"81","author":"Zou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0045","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.3390\/cancers13205189","article-title":"Epstein\u2013Barr Virus\u2014Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0050","doi-asserted-by":"crossref","unstructured":"Ozturk V, Yikilmaz AS, Kilicarslan A, Bakanay SM, Akinci S, Dilek Imdat. The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma. Clinical Lymphoma, Myeloma & Leukemia n.d.;20:375\u201381. doi:https:\/\/doi.org\/10.1016\/j.clml.2019.11.021.","DOI":"10.1016\/j.clml.2019.11.021"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.28.20140066","article-title":"T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo","volume":"28","author":"Tang","year":"2014","journal-title":"J Biomed Res"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/2042-4280-2-8","article-title":"Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations","volume":"2","author":"Fox","year":"2011","journal-title":"Herpesviridae"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0065","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2017.74.3179","article-title":"Tumor-specific T-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed Hodgkin lymphoma","volume":"36","author":"Bollard","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V116.21.560.560","article-title":"Administration of tumor-specific cytotoxic T lymphocytes engineered to resist TGF-\u00df to patients with EBV-associated lymphomas","volume":"116","author":"Bollard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/theoncologist.2010-0213","article-title":"Epstein-Barr Virus\u2013Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far","volume":"16","author":"Castillo","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajh.24370","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Castillo","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0090","series-title":"CE. WHO classification of Tumours of Haematopoietic and lymphoid tissues","volume":"vol. 117","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0095","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.semdp.2021.04.004","article-title":"Rare EBV-associated B cell neoplasms of the gastrointestinal tract","volume":"38","author":"Volaric","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein\u2212Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/his.13197","article-title":"Reappraisal of Epstein\u2013Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells","volume":"71","author":"Ohashi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.50.11.911","article-title":"Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas","volume":"50","author":"Brink","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0130","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.7314\/APJCP.2013.14.6.3963","article-title":"Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining","volume":"14","author":"Ishtiaq","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.semdp.2018.02.001","article-title":"Reexamining post-transplant lymphoproliferative disorders: newly recognized and enigmatic types","volume":"35","author":"Aguilera","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0145","first-page":"33","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0155","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein-Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","article-title":"Co-infections, inflammation and oncogenesis: future directions for EBV research","volume":"26","author":"Rickinson","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","article-title":"Characteristics of early and late PTLD development in pediatric solid organ transplant recipients","volume":"95","author":"Schober","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.anndiagpath.2024.152286_bb0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am. J. Transplant."}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:36:05Z","timestamp":1761078965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S1092913424000236"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152286","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152286"}}